| abstract |
The invention includes dihydrate dehydroepiandrosterone, analog (s) or salt (s) thereof, covalently linked to sulfuric acid, alone and with a pharmaceutically or veterinarily acceptable carrier, And a powder formulation having a particle size of about 0.1 μm to about 100 μm. The formulation can be used to treat or prevent asthma, chronic obstructive pulmonary disease, lung inflammation, SARS, and other respiratory diseases or conditions. The formulation can be prepared by jet milling and delivered through the respiratory cavity or other routes. The formulation is provided in devices and therapeutic kits. |